Cynata Reports Positive Progress in Clinical Trials
Cynata Therapeutics achieves key milestones in clinical trials with strong cash reserves, gearing up for impactful patient treatments. Stay tuned for updates!
We use AI to generate a series of articles on company ASX announcements and publish both on our APP and across a company’s social media channels.
Cynata Therapeutics achieves key milestones in clinical trials with strong cash reserves, gearing up for impactful patient treatments. Stay tuned for updates!
Evion is making strides in the Maniry Graphite Mine project with over 100 local community agreements. Anticipated environmental approvals will enhance development efforts and local benefits.
Rhythm Biosciences showcases significant Q3 achievements, progressing in ColoSTAT® development and achieving successful integration of geneType™ assets, bolstering future growth.
Flynn Gold reveals high-grade gold targets at Golden Ridge Project. Sampling shows up to 44.5g/t Au at Double Event Prospect, with further drilling planned.
EP&T Global shows strong Q1 2025 performance with a 32% increase in cash receipts and positive operating cash flows. Exciting times ahead with Coda Cloud billing starting!
Stellar Resources advances on the Heemskirk Tin Project with encouraging drill results and a strong PFS focus. Major ore sorting success suggests optimization for future operations.
FBM is gearing up for substantial gold exploration success at Kal North, expanding landholdings and backed by a strong cash position of A$7.4 million.
DevEx Resources announces promising uranium exploration progress, identifying multiple large-scale targets around the Nabarlek Mine and preparing for immediate field activities.
Critical Minerals Group announces a $7.3 million Entitlement Offer to underpin growth initiatives, including key projects at the Lindfield site.